Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

BIBW 2992 (Afatinib) and Vinorelbine

This study has been terminated.
(The recruitment was discontinued because of failure to meet expected enrolment goals)
Sponsor:
Collaborator:
Boehringer Ingelheim
Information provided by:
University of Magdeburg
ClinicalTrials.gov Identifier:
NCT01531764
First received: February 9, 2012
Last updated: October 17, 2013
Last verified: February 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2013
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)